Learn More About the Aptima® Virology assays on the Panther® System.

Contact a rep about the Aptima HIV-1 Quant Dx assay for the diagnosis of HIV-1

The Aptima HIV-1 Quant assay

Product Information

Package Insert (PI)

Product Information Sheet

Press Release

Posters and Publications

Amendola A et al. Evaluation of the new Aptima HIV-1 Quant Dx assay for HIV-1 RNA quantification in plasma of infected individuals: a comparison with Abbott RealTime HIV-1 assay. Paper presented at: ECCMID 2015; April 25-28, 2015; Copenhagen, Denmark.

Ehret R et al. Comparison of the new Hologic Aptima HIV-1 Quant Dx Assay with the established Abbott RealTime in HIV-1 viral load measurement. Paper presented at: ECCMID 2015; April 25-28, 2015; Copenhagen, Denmark.

Hatzakis A et al. Comparison of the Aptima HIV-1 quant assay to the COBAS AmpliPrep/COBAS TaqMan HIV-1 test, v2.0. Paper presented at: The 20th Meeting of the International Society for Sexually Transmitted Diseases Research; July 14-17, 2013; Vienna, Austria.

Hopkins M et al. Comparative performance of the new Aptima HIV-1 Quant Dx assay with three commercial PCR-based HIV-1 RNA quantitation assays. J Clin Virol. 2015;69:56-62.

Manak M. Evaluation of the Hologic (Gen-Probe) Aptima HIV-1 RT quantitative assay on HIV-1 subtypes. Paper presented at: The 21st Conference on Retroviruses and Opportunistic Infections; March 3-6, 2014; Boston, MA.

O’Shea S et al. Performance of the Aptima® HIV-1 Quant Dx Assay on the Panther System, International Journal of Medical, Health, Biomedical, Bioengineering and Pharmaceutical Engineering. 2015;9(5):373-376.

Schalasta G et al. Comparative evaluation of the Aptima HIV-1 Quant Dx assay and COBAS TaqMan HIV-1 v2.0 assay using the Roche High Pure System for the quantification of HIV-1 RNA in plasma [published online August 18, 2015]. Clin Chem Lab Med. 2015. doi: 10.1515/cclm-2015-0522.

The Aptima HCV Quant Dx assay

Product Information

Package Insert (PI)

Product Information Sheet

Press Release

Posters and Publications

Clark C et al. Comparison of the Aptima® HCV Quant Dx Assay to the COBAS® AmpliPrep/COBAS® TaqMan® HCV Test v2.0 and the Abbott® RealTime HCV Assay. Paper presented at: 13th European Meeting on HIV & Hepatitis; June 3-5, 2015; Barcelona, Spain

Worlock A et al. Clinical & Analytical Performance Comparison of the Aptima® HCV Quant Dx Assay to the COBAS® AmpliPrep/COBAS® TaqMan® HCV Test, v2.0 and Abbott® RealTime HCV Assay. Paper presented at: ECCMID; 2015 April 25-28, 2015; Copenhagen, Denmark.

Safety data sheets

Access Aptima Virology safety data sheets here.

CONTACT US

HOLOGIC

COUNTRIES

*The Aptima Zika Virus assay:

This test has not been FDA cleared or approved;
This test has been authorized by FDA under an EUA for use by authorized laboratories;
This test has been authorized only for the detection of RNA from Zika virus and diagnosis of Zika virus infection, not for any other viruses or pathogens; and
This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection under section 564(b)(1) of the Act, 21 U.S.C.§ 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

©2017 Hologic, Inc. All rights reserved. Hologic, The Science of Sure, Aptima, Panther, and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries. This information is intended for medical professionals in the U.S. and is not intended as a product solicitation or promotion where such activities are prohibited. Because Hologic materials are distributed through websites, eBroadcasts and tradeshows, it is not always possible to control where such materials appear. For specific information on what products are available for sale in a particular country, please contact your local Hologic representative or write to diagnostic.solutions@hologic.com

Explore the Data